Merck accused of dressing marketing up as science
Date: 19 Aug 2008
A study carried out by Merck on its now withdrawn painkiller Vioxx that showed whether the drug was easier on the stomach than an alternative was actually conducted as part of a marketing programme by the company, according to a recent report.
The report, which draws from internal company memos and reports on the Advantage study, claims that the company's marketing department engaged in 'stealth marketing' by enlisting doctors in a study whose purpose was primarily to get the doctors used to using the drug and to encourage them to promote it via word of mouth.
The authors alleged that the company selected the most influential doctors. The company denied that the study had been motivated by marketing.
Bookmark with:
Del.icio.us |
Digg |
reddit |
Facebook |
StumbleUpon
Comments
You must be logged in to add comments
Special Feature
Social responsibility and finance - on the precipice
In a recent article, the BBC's economics editor Robert Peston highlighted the fact that in 2012 the chances are that the economy - punch drunk as it is from the various flavours of debt crisis it has been pummelled with over the course of the year - will be hit by the collapse of a major bank and / or government.
Similar news stories
Glencore attacked by UN and others for seeing business opportunity in a crisis - 23 Aug 2012
Chile: Fast food companies sued over marketing to children - 2 Aug 2012
US: GlaxoSmithKline boss promises company has changed after $3bn mis-selling fine - 26 Jul 2012
UK: Alcohol advertising under pressure from MPs - 20 Jul 2012
China: Wal-Mart apologises for mislabelled pork - 11 Oct 2011
From the same country
US: Shell Nigeria case blow for Alien Tort campaigners - 22 Apr 2013
US: BP kicks back over 'fictitious' compensation pay-outs - 17 Mar 2013
US: Las Vegas Sands owns up to bribery of foreign officials - 3 Mar 2013
Defence firms poor on anti-corruption measures - 4 Oct 2012
US: GlaxoSmithKline boss promises company has changed after $3bn mis-selling fine - 26 Jul 2012
Other stories about this company
Drug companies cut vaccine prices in search of a more humane business model - 6 Jun 2011
Australia: Merck used fake academic journals to promote Vioxx - 14 May 2009
Merck settles Vioxx claims for $4.85bn - 9 Nov 2007
Currently most popular stories
Procter & Gamble most consistent top corporate citizen (20 May 2004)
AccountAbility hits back at 'untenable' standards board (14 Jan 2011)
Former Yukos executives to complain to human rights court (22 Mar 2006)
Arguments against corporate social responsibility - redoubled (26 Oct 2008)
Peru: Pluspetrol in spotlight over Amazon rainforest pollution (27 Mar 2013)



No comments added - be the first!